Verition Fund Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.64M | Hold |
567,683
| – | – | 0.01% | 1560 |
|
|
2025
Q1 | $1.22M | Sell |
567,683
-470,065
| -45% | -$1.01M | 0.01% | 1509 |
|
|
2024
Q4 | $4.02M | Sell |
1,037,748
-124,002
| -11% | -$480K | 0.02% | 818 |
|
|
2024
Q3 | $7.61M | Sell |
1,161,750
-432,400
| -27% | -$2.83M | 0.04% | 469 |
|
|
2024
Q2 | $11.6M | Buy |
1,594,150
+92,531
| +6% | +$671K | 0.06% | 256 |
|
|
2024
Q1 | $11.4M | Sell |
1,501,619
-1,309,512
| -47% | -$9.94M | 0.08% | 241 |
|
|
2023
Q4 | $12.8M | Sell |
2,811,131
-89,407
| -3% | -$407K | 0.1% | 165 |
|
|
2023
Q3 | $11.5M | Buy |
2,900,538
+183,825
| +7% | +$726K | 0.13% | 165 |
|
|
2023
Q2 | $8.5M | Buy |
2,716,713
+777,891
| +40% | +$2.43M | 0.11% | 218 |
|
|
2023
Q1 | $8.78M | Buy |
1,938,822
+462,598
| +31% | +$2.1M | 0.12% | 199 |
|
|
2022
Q4 | $6.1M | Buy |
1,476,224
+84,888
| +6% | +$351K | 0.1% | 229 |
|
|
2022
Q3 | $4.45M | Buy |
1,391,336
+987,446
| +244% | +$3.16M | 0.05% | 411 |
|
|
2022
Q2 | $792K | Sell |
403,890
-20,709
| -5% | -$40.6K | 0.02% | 1126 |
|
|
2022
Q1 | $1.72M | Buy |
424,599
+188,764
| +80% | +$765K | 0.02% | 730 |
|
|
2021
Q4 | $2.55M | Buy |
235,835
+156,179
| +196% | +$1.69M | 0.02% | 489 |
|
|
2021
Q3 | $918K | Sell |
79,656
-165,019
| -67% | -$1.9M | 0.01% | 742 |
|
|
2021
Q2 | $2.4M | Buy |
244,675
+15,374
| +7% | +$151K | 0.02% | 382 |
|
|
2021
Q1 | $3.35M | Buy |
229,301
+106,194
| +86% | +$1.55M | 0.04% | 218 |
|
|
2020
Q4 | $2.64M | Buy |
123,107
+71,107
| +137% | +$1.52M | 0.02% | 244 |
|
|
2020
Q3 | $789K | Buy |
+52,000
| New | +$789K | 0.02% | 364 |
|